The primary objective of modern psychopharmacological intervention within the schizophrenia spectrum is the stabilization of neurocognitive functioning via long-term dopamine receptor antagonism. However, accumulating longitudinal data reveals a profound structural and functional paradox: the prolonged administration of both first- and second-generation antipsychotics is significantly correlated with progressive cortical volume reduction and the worsening of core executive dysfunction. This paper reviews the empirical literature tracking these structural shifts, focusing on high-resolution magnetic resonance imaging (MRI) studies and prospective longitudinal cohorts that isolate medication effects from intrinsic disease processes. We evaluate the pathophysiological mechanisms underpinning this attrition, demonstrating that continuous D2 receptor blockade leads to compensatory receptor upregulation, neuroleptic-induced supersensitivity psychosis, and microglial activation that accelerates prefrontal and frontal lobe tissue loss. Functionally, this cortical thinning manifests as a progressive decline in executive control, working memory, and adaptive behavior, trapping individuals in a state of chronic dependency and structural disability.
Daphne Garrido (Mon,) studied this question.